Continuous format high throughput screening

• US 5,976,813 A
• Filed: 12/12/1997
• Issued: 11/02/1999
• Est. Priority Date: 12/12/1997
• Status: Expired due to Term

• Current Assignee: Abbvie Incorporated
• Original Assignee: Abbott Laboratories Incorporated
• Inventors: Burns, David J., Beutel, Bruce A., Schurdak, Mark E., Voorbach, Martin J., Joseph, Mary K.
• Primary Examiner(s): STUCKER, JEFFREY J
• Application Number:
  US08/990,168
• Time in Patent Office: 690 Days
• Field of Search: 435/7.1, 435/7.92, 435/7.93, 435/7.94, 435/7.9, 435/975, 436/170, 436/518, 436/531, 436/535, 436/810, 422/56
• US Class Current: 506/7
• CPC Class Codes: B01J 2219/00527 Sheets
• CPC Class Codes: B01J 2219/00585 Parallel processes
• CPC Class Codes: B01J 2219/00596 Solid-phase processes
• CPC Class Codes: B01J 2219/00605 the compounds being directly bound or immobilised to solid supports
• CPC Class Codes: B01J 2219/0061 The surface being organic
• CPC Class Codes: B01J 2219/00614 Delimitation of the attachment areas
• CPC Class Codes: B01J 2219/0063 Other, e.g. van der Waals forces, hydrogen bonding
• CPC Class Codes: B01J 2219/00641 the porous medium being continuous, e.g. porous oxide substrates
• CPC Class Codes: B01J 2219/00659 Two-dimensional arrays
• CPC Class Codes: B01J 2219/00707 separated from the reactor apparatus
• CPC Class Codes: G01N 33/54313 the carrier being characterised by its particulate form

Abstract

Continuous format high throughput screening (CF-HTS) using at least one porous matrix allows the pharmaceutical industry to simultaneously screen large numbers of chemical entities for a wide range of biological or biochemical activity. In addition, CF-HTS is useful to perform multi-step assays.

Claims

1. A process to simultaneously test a multitude of samples of different substances for their ability to enhance or inhibit a biological process comprising,

a) depositing in an array a small volume of each of more than 96 samples of distinct substances onto a planar porous matrix containing or carrying a uniformly dispersed assay reagent such that each distinct substance is centered at its own distinct site and the identity of each substance can be determined from its deposition site, and

b) observing the interaction of each substance with said assay reagent and correlating it to said substance'"'"'s ability to enhance or inhibit said biological process.

5. The process of claim 1 or 2 or 3 or 4 wherein one of the uniformly dispersed assay reagents is a macromolecule.

6. The process of claim 1 or 2 or 3 or 4 wherein one of the uniformly dispersed assay reagents is an enzyme.

7. The process of claim 1 or 2 or 3 or 4 wherein one of the uniformly dispersed assay reagents is a crude biological extract.

8. The process of claim 1 or 2 or 3 or 4 wherein one of the uniformly dispersed. assay reagents are organelles.

9. The process of claim 1 or 2 or 3 or 4 wherein one of the uniformly dispersed assay reagents are whole cells.

10. The process of claim 1 or 2 or 3 or 4 wherein a uniformly dispersed assay reagent are whole cells carried on one surface of a planar porous matrix.

11. The process of claim 10 wherein said interaction is observed by contacting said porous matrix with a solution or liquid suspension of a a reagent or a porous matrix containing a reagent which in either case aids in the visualization of a protein whose expression in said whole cells is the biological process being evaluated.

2. A process to simultaneously test a multitude of samples of different substances for their ability to enhance or inhibit a biological process comprising,

a) depositing in an array a small volume of each of more than 96 samples of distinct substances onto a planar matrix such that each distinct substance is centered at its own distinct site and the identity of each substance can be determined from its deposition site,

b) bringing said matrix into contact with a porous matrix containing or carrying a uniformly dispersed assay reagent and allowing some of each substance to diffuse into said porous matrix in a manner that the spacial location of each diffused substance can be correlated to the site on said planar matrix at which said substance was originally deposited, and

c) conducting an assay to determine the ability of each diffused substance to enhance or inhibit said biological process.

3. A process to simultaneously test a multitude of samples of different substances for their ability to enhance or inhibit a biological process comprising,

a) depositing in an array a small volume of each of more than 96 samples of distinct substances onto a planar matrix such that each distinct substance is centered at its own distinct site and the identity of each substance can be determined from its deposition site,

b) bringing said planar matrix into contact with a first porous matrix containing or carrying a uniformly dispersed first assay reagent and allowing some of each substance to diffuse into said porous matrix in a manner that the spacial location of each diffused substance can be correlated to the site on said planar matrix at which said substance was originally deposited,

c) bringing said first porous matrix into contact with a second matrix carrying or containing a second uniformly dispersed assay reagent and allowing the second assay reagent to diffuse into the first porous matrix or allowing each substance and the first reagent to diffuse into the second matrix, in the latter case assuring that the diffusion occurs in such a manner that the location of each substance in the second matrix can be correlated to the site on said planar matrix at which said substance was originally deposited, and

d) evaluating the ability of each substance to enhance or inhibit said biological process.

4. A process to simultaneously test a multitude of samples of different substances for their ability to enhance or inhibit a biological process comprising,

a) depositing in an array a small volume of each of more than 96 samples of distinct substances onto a first planar porous matrix containing or carrying a uniformly dispersed first assay reagent such that each distinct substance is centered at its own distinct site and the identity of each substance can be determined from its deposition site,

b) bringing said first porous matrix into contact with a second planar matrix carrying or containing a second uniformly dispersed assay reagent and allowing the second assay reagent to diffuse into the first porous matrix or allowing each substance and the first reagent to diffuse into or onto the second matrix, in the latter case assuring that the diffusion occurs in such a manner that the location of each substance in or on the second matrix can be correlated to the site on said first porous matrix at which said substance was originally deposited, and

c) evaluating the ability of each substance to enhance or inhibit said biological process.

12. The process of claim 4 wherein the first assay reagent is a labeled ligand and the second assay reagent is an immobilized receptor for said ligand.

13. The process of claim 12 wherein the second planar matrix is washed to remove any labeled ligand which diffused onto or into said second planar matrix but did not become bound to said immobilized receptor.

14. The process of claim 13 wherein said second planar matrix is contacted with a solution or liquid suspension of a reagent or a porous matrix containing a reagent which in either case aids in the visualization of labeled ligand not removed by the washing step.